A HUMAN TOXOPLASMA GONDII VACCINE
$438,932N43FY2016AINIH
Prommune, Inc., Omaha NE
Investigators
Abstract
To apply a novel technology platform to the development of a Toxoplasma gondii vaccine.
View original record on NIH RePORTER →Prommune, Inc., Omaha NE
To apply a novel technology platform to the development of a Toxoplasma gondii vaccine.
View original record on NIH RePORTER →